Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: straight life who wrote (1472)	1/13/2000 11:25:00 AM
From: LiPolymer	Respond to of 1754

VISX down big again, below the previous low of ~$49-1/2 reached on the negative ITC ruling. Is the market's response today correct, or merely "near-sighted"? I have a few Mar55 calls that hope this is another overreaction. Regards.

To: straight life who wrote (1472)	1/13/2000 11:27:00 AM
From: Robert G. Harrell	Read Replies (3) \| Respond to of 1754

Perhaps we can draw a little comfort from the fact that Michael Murphy doesn't have a real good track record. Sometime in the last few months I read a short piece in one of the investment magazines I get, probably SmartMoney or Worth, that revealed the negative truth about the fund Murphy manages. If I can find it I'll post a link. I'm afraid we're in for a long wait for this stock to recover. It may take several quarters to disprove (hopefully) the street's assumption that a price war in eye surgery will be negative for VISX.